Investor List:

Top Consumer Health Series B Investors in Canada (6)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Consumer Health investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Lex Alvarez, Principal at SilverCircle
Lex Alvarez
SilverCircle·Principal
Sweet spot: $1M
Range: $250K - $2.0M
Investors in LatAm (Latin America), Investors in Canada, Investors in Europe, Investors in United States
Investors in Gaming/eSports (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Gaming/eSports (Seed), Investors in Payments (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Seed), Investors in Payments (Seed), Investors in Consumer Internet (Seed), Investors in Marketplaces (Seed), Investors in Web3/Blockchain (Seed), Investors in Enterprise (Seed), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in Marketplaces (Seed), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Payments (Seed), Investors in Gaming/eSports (Seed), Investors in Consumer Health (Seed), Investors in Web3/Blockchain (Seed), Investors in Web3/Crypto (Seed), Investors in Marketplaces (Seed), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in FinTech (Seed), Investors in Gaming/eSports (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Gaming/eSports (Series A), Investors in Payments (Series A), Investors in Web3/Blockchain (Series A), Investors in Web3/Crypto (Series A), Investors in Web3/Crypto (Series A), Investors in Payments (Series A), Investors in Web3/Blockchain (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Series A), Investors in Marketplaces (Series A), Investors in Marketplaces (Series A), Investors in Enterprise (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in Payments (Series A), Investors in Gaming/eSports (Series A), Investors in Consumer Health (Series A), Investors in Web3/Blockchain (Series A), Investors in Marketplaces (Series A), Investors in Web3/Crypto (Series A), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in Consumer Health (Series B), Investors in Gaming/eSports (Series B), Investors in Web3/Blockchain (Series B), Investors in Gaming/eSports (Series B), Investors in Web3/Crypto (Series B), Investors in Payments (Series B), Investors in Consumer Health (Series B), Investors in Payments (Series B), Investors in Web3/Crypto (Series B), Investors in Web3/Blockchain (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Internet (Series B), Investors in Marketplaces (Series B), Investors in Enterprise (Series B), Investors in Marketplaces (Series B), Investors in SaaS (Series B), Investors in FinTech (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in SaaS (Series B), Investors in Payments (Series B), Investors in Gaming/eSports (Series B), Investors in Consumer Health (Series B), Investors in Web3/Blockchain (Series B), Investors in Marketplaces (Series B), Investors in Web3/Crypto (Series B), Investors in SaaS (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in Canada (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Shalva Gozland, Investor at Insight Partners
Shalva Gozland
Sweet spot: $10.0M
Range: $50K - $1.0B
Investors in New Zealand, Investors in Australia, Investors in Canada, Investors in Europe, Investors in Israel, Investors in United States
Investors in Generative Tech/AI (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in AutoTech (Seed), Investors in Consumer Health (Seed), Investors in Enterprise Applications (Seed), Investors in Generative Tech/AI (Seed), Investors in Enterprise Applications (Seed), Investors in Health & Hospital Services (Seed), Investors in AutoTech (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in AutoTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise Applications (Seed), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in Consumer Health (Series A), Investors in AutoTech (Series A), Investors in Digital Health (Series A), Investors in Enterprise Applications (Series A), Investors in Generative Tech/AI (Series A), Investors in AutoTech (Series A), Investors in Consumer Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Enterprise Applications (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in AutoTech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Enterprise Applications (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Enterprise Applications (Series B), Investors in AutoTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in AutoTech (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in AutoTech (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise Applications (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in Canada (Other Lists), Investors in Female Investors (Other Lists), Investors in Israel (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of Nordic Eye, Partner at Nordic Eye
Nordic Eye
Nordic Eye·Partner
Sweet spot: $5.0M
Range: $2.0M - $10.0M
Investors in Europe, Investors in United States, Investors in Canada, Investors in Singapore
Investors in Consumer Health (Series A), Investors in MarketingTech (Series A), Investors in Logistics (Series A), Investors in Robotics (Series A), Investors in EnergyTech (Series A), Investors in E-commerce (Series A), Investors in IoT (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in AI (Series A), Investors in MarketingTech (Series A), Investors in Logistics (Series A), Investors in Robotics (Series A), Investors in EnergyTech (Series A), Investors in IoT (Series A), Investors in Consumer Health (Series A), Investors in E-commerce (Series A), Investors in SaaS (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Consumer Health (Series B), Investors in MarketingTech (Series B), Investors in Logistics (Series B), Investors in EnergyTech (Series B), Investors in Robotics (Series B), Investors in IoT (Series B), Investors in E-commerce (Series B), Investors in FinTech (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in MarketingTech (Series B), Investors in Logistics (Series B), Investors in EnergyTech (Series B), Investors in Robotics (Series B), Investors in IoT (Series B), Investors in Consumer Health (Series B), Investors in E-commerce (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in FinTech (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists)
Photo of Chris Angelatos, Associate at Esplanade HealthTech Ventures
Chris Angelatos
Sweet spot: $2.0M
Range: $500K - $7.5M
Investors in Israel, Investors in Europe, Investors in United States, Investors in Canada
Investors in Parenting/Families (Seed), Investors in Parenting/Families (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Parenting/Families (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Parenting/Families (Series A), Investors in Parenting/Families (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Parenting/Families (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Parenting/Families (Series B), Investors in Parenting/Families (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Wellness & Fitness (Series B), Investors in Consumer Health (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Parenting/Families (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Israel (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Daniella Kranjac, General Partner at AVANT BIO
Daniella Kranjac
AVANT BIO·General Partner
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Switzerland, Investors in United Kingdom, Investors in Europe, Investors in Canada, Investors in United States
Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Female Investors (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Marissa Moore, Investor at OMERS Ventures
Marissa Moore
OMERS Ventures·Investor
Sweet spot: $10
Range: $5 - $25
Investors in Canada, Investors in United Kingdom, Investors in United States
Get new data & insights delivered to your inbox